Anti‐monkeypox virus‐neutralizing activities of human immunoglobulin manufactured between 1999 and 2021 and derived from donors in the United States and Japan

Documenti analoghi

• Non‐neutralizing antibody profiles against hepatitis B virus: A comparative study of Japanese‐ and US‐donor‐derived intramuscular human hepatitis B‐specific immunoglobulin preparations
  di: Tatsuki Miyamoto, et al.
  Pubblicazione: (2024)
• The importance of confirmatory assays in testing blood donors for human T‐cell lymphotropic virus
  di: Marina Lobato Martins, et al.
  Pubblicazione: (2024)
• Dengue, chikungunya and Zika virus surveillance in blood donors in Brazil , 2019–2021
  di: Eduard Grebe, et al.
  Pubblicazione: (2025)
• Risk factors for incident human immunodeficiency virus infection in South African blood donors
  di: Avril Swarts, et al.
  Pubblicazione: (2025)
• Protection of fundamental human rights by improving patient access to plasma‐derived therapies and donor health protection
  di: Jean‐Baptiste Thibert, et al.
  Pubblicazione: (2026)